29590 - Post Office: Small Businesses (Answered)

Jonathan Reynolds
To ask the Secretary of State for Business, Innovation and Skills, if he will make representations to the Post Office on providing free business banking services to small and medium-sized enterprises.

George Freeman

29649 - Nabiximols (Answered)

Mr Roger Godsiff
To ask the Secretary of State for Health, pursuant to the Answer of 24 February 2016 to Question 28215, what the implications for the availability of Sativex to Multiple Sclerosis patients are of the NICE guidance that Sativex is not recommended as a treatment option.

George Freeman

The National Institute for Health and Care Excellence’s (NICE) clinical guideline on the management of multiple sclerosis, published in October 2014, does not recommend Sativex as a cost effective use of National Health Service resources.

29425 - Human Embryo Experiments (Answered)

Robert Flello
To ask the Secretary of State for Health, whether he has had discussions with the Human Fertilisation and Embryology Authority after its authorisation of a licence for gene editing of human embryos by means of CRISPR-Cas9 on the process of ethical approval being granted for such a licence.

George Freeman

29427 - Human Embryo Experiments (Answered)

Robert Flello
To ask the Secretary of State for Health, what the guidance is on licences applied for to the Human Fertilisation and Embryology Authority being granted before receiving ethical approval; and what proportion of such licences have been so granted in each of the last three years.

George Freeman

29426 - Human Embryo Experiments (Answered)

Robert Flello
To ask the Secretary of State for Health, if he will take steps to ensure that information given to patients or donors explaining research to which they have consented on genome editing in human embryos by means of CRISPR-Cas9 will be publicly available.

George Freeman

29388 - NHS: Drugs (Answered)

Edward Argar
To ask the Secretary of State for Health, what the timetable is for the publication of the findings of the Accelerated Access Review.

George Freeman

Sir Hugh Taylor published his interim report to the review on 27 October 2015. The review will conclude with Sir Hugh’s final recommendations to Government which are expected in spring 2016.

29395 - Clinical Commissioning Groups (Answered)

Joan Ryan
To ask the Secretary of State for Health, whether his Department has made an assessment of the proportion of GPs on the executive bodies of clinical commissioning groups who have a financial interest in the services they are commissioning.

George Freeman

29394 - Clinical Commissioning Groups (Answered)

Joan Ryan
To ask the Secretary of State for Health, what recent assessment he has made of the effectiveness of NHS guidance to clinical commissioning groups on their responsibility to manage conflicts of interest when commissioning and providing services.

George Freeman

29393 - Clinical Commissioning Groups (Answered)

Joan Ryan
To ask the Secretary of State for Health, what recent representations he has received from (a) the British Medical Journal, (b) GP networks, (c) Monitor and (d) other organisations on conflicts of interest in the commissioning of services by clinical commissioning groups.

George Freeman

29211 - Colorectal Cancer: Drugs (Answered)

Sir David Amess
To ask the Secretary of State for Health, what discussions his Department has had with NICE and NHS England on the availability of Erbitux for metastatic colorectal cancer patients.

George Freeman

I refer the hon. Member to the answer I gave on 24 February 2016 to Question 27585.

Pages